IPO
Medtronic plc announced the commencement of two cash tender offers by its wholly-owned indirect subsidiaries, Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc.
The board of directors of Medtronic plc approved an 8 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.54 per ordinary share.
Galapagos NV announces a share capital increase arising from warrant exercises.
This week marked initial public offering news from six biopharma companies. Here’s a look.
Lonza reports restated 2018 financials for sales, CORE EBITDA and CORE EBIT
MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results as of and for the year ended December 31, 2018 as well as operative highlights.
Evotec SE announced that its shareholders approved all proposals the Company’s Management put to vote at the Company’s Annual General Meeting 2019 with very strong supporting majorities.
Proceeds will facilitate clinical development of Imcyse’s technology in type 1 diabetes, multiple sclerosis and other indications
Galapagos NV received a transparency notification from The Capital Group Companies, Inc.
GENFIT announced the results of the voting by shareholders at the Ordinary Shareholders’ Meeting which took place on June 13, 2019, in Lille, France.
PRESS RELEASES